A large number of proteins and peptides (vaccines, enzymes, hormones, cytokines, antibodies nucleic acids and globulins) have found possible applications as biopharmaceuticals because they can be used for the treatment of many diseases, such as diabetes (insulin), and malignant disorders, including cancer. This evidence concerns the gene INS and diabetes mellitus.